Cart
sales@molnova.com
Thrombin inhibitor 5
CAS No. 328108-09-4
Thrombin inhibitor 5( —— )
Catalog No. M37681 CAS No. 328108-09-4
Thrombin inhibitor 5 (compound 385) is a thrombin inhibitor with IC50 values ranging from 0.1 μM to 1 μM, suitable for venous thromboembolism research.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 50 | In Stock |
|
| 2MG | 30 | In Stock |
|
| 5MG | 51 | In Stock |
|
| 10MG | 79 | In Stock |
|
| 25MG | 157 | In Stock |
|
| 50MG | 231 | In Stock |
|
| 100MG | 331 | In Stock |
|
| 200MG | 448 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameThrombin inhibitor 5
-
NoteResearch use only, not for human use.
-
Brief DescriptionThrombin inhibitor 5 (compound 385) is a thrombin inhibitor with IC50 values ranging from 0.1 μM to 1 μM, suitable for venous thromboembolism research.
-
DescriptionThrombin inhibitor 5 (compound 385) is a thrombin inhibitor, with IC50s ranging from 0.1 μM to 1 μM. Thrombin inhibitor 5 can be used for research of venous thromboembolism.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
RecptorOthers
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number328108-09-4
-
Formula Weight264.21
-
Molecular FormulaC11H9FN4O3
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 31.25 mg/mL (118.28 mM; Ultrasonic (<80°C)
-
SMILESCOC(=O)c1n[nH]c(NC(=O)c2ccc(F)cc2)n1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
1-O-trans-cinnamoyl-...
1-O-trans-Cinnamoyl-β-D-glucopyranose is a nature product. 1-O-trans-Cinnamoyl-β-D-glucopyranose can be isolated from fruits.
-
(R)-Omeprazole Sodiu...
(R)-Omeprazole (sodium) (Standard) is the analytical standard of (R)-Omeprazole (sodium). This product is intended for research and analytical applications. (R)-Omeprazole sodium is a gastric acid resistant compound with activity to inhibit gastric acid secretion. (R)-Omeprazole sodium is metabolized in vivo, and its metabolism is primarily affected by cytochrome P450 enzymes. The interaction between (R)-Omeprazole sodium and mannitol may affect its bioavailability in formulations. (R)-Omeprazole sodium exhibits reversible direct and metabolism-dependent inhibition of CYP2C19.
-
Neoglucobrassicin
Neoglucobrassicin is a natural product for research related to life sciences.
